Select Page

MVA-members DNB and Back Bay Life Science Advisors form strategic partnership

May 24, 2023

DNB and Back Bay Life Science Advisors have announced a strategic partnership to drive global healthcare growth and innovation.

DNB will make a financial investment in Back Bay to formalize the Partnership, which will provide strategic advisory and investment banking capabilities across the spectrum of development and commercialization to global biopharma, medtech, healthtech, diagnostic and healthcare service companies, ranging from pre-clinical startups to global multinationals.

“DNB’s investment in Back Bay is a milestone in our commitment to the healthcare sector. We endeavor to make a positive impact on our communities, specifically in the areas of healthcare and wellness, and to support innovative companies developing new treatments and technologies in human healthcare,” said Alexander Opstad, Executive Vice President and Head of DNB Markets, the Capital Markets and Investment Banking arm of DNB

“As companies advancing healthcare assets are met with scientific, business and
funding challenges, our Partnership’s integration of strategy and transaction execution excellence across investment and corporate banking functions becomes critical to furthering improvements in global healthcare. The boards and managements of healthcare companies will now be able to choose one dedicated partner for commercial development and corporate finance guidance and execution.” said Jonathan P. Gertler, CEO of Back Bay Life Science Advisors (and former MVA Annual Summit keynote speaker)

Read full press release online

Most recent news